I will say that this PPS drop is getting really old now.
I will say that this PPS drop is getting really old now. We've had selloff after selloff for months.
It's been blamed on a Fund Company, a company that did not sell all it's assets and who knows what else. But, the PPS keeps dropping.
We are now waiting on a Dividend approval that we are told should be coming 'soon' in days (whatever that means now).
Every CC, we hear all the great news that will be coming down the pipeline. Wonderful news in fact. And the future looks really promising. It's the present that Generex seems to keep having a problem with every single day.
All I am asking is for the Management team to finally get it right. Stop the squabbling, make right decisions, work out the issues, figure out how to get NGIO listed 'ON TIME', get the dividend out to everyone without another delay this time and get the PPS up as all the shareholders have suffered enough.
Shareholders have been loyal to Generex, some for years and years. Some for months only, but they have been loyal and bought shares even during all this time of 'trouble'. They are still remaining loyal.
It's time to turn this all around.
1
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Market Dynamics Amid Greenland Tensions Recent market developments suggest that investors are recalibrating their strategies in response to heightened tensions surrounding Greenland. The prominent rise in gold prices coupled with a decline in global equities signals a significant shift in investor sentiment. This behavior indicates that many now perceive a...
Continue Reading
GDIT Awarded Significant Mission Partner Environment Contract General Dynamics Information Technology (GDIT), a notable unit of General Dynamics, has recently obtained a groundbreaking contract valued at $5.6 billion. This exciting venture represents a major stride towards enhancing secure communication frameworks for military and coalition partnerships around the globe....
Continue Reading
Significant Growth in Additive Manufacturing Industry The latest edition of Wohlers Report reveals encouraging developments in the additive manufacturing (AM) sector. This report marks a milestone, providing deeper insights and data than ever before. Wohlers Report 2025 Overview Each year, the Wohlers Report features extensive research and findings on the additive...
Continue Reading
Peachtree Lighting Unveils a Modern Website for Growth Peachtree Lighting, a leading name in commercial and architectural lighting, proudly announces the launch of its redesigned website. This transformation signifies a pivotal moment in the company’s journey, heralded by the new leadership of President Kyle Leighton. The newly launched website serves as a central tool...
Continue Reading
Polar Power's Strategic Reverse Stock Split Initiative Polar Power, Inc. (NASDAQ: POLA), a leader in providing innovative energy solutions such as prime, backup, solar hybrid power, and microgrid technology, has recently unveiled its plans to implement a reverse stock split. This decision aims to enhance its compliance standing on the Nasdaq Capital Market, where its...
Continue Reading